Personalis Inc 04X-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 6:19 PM CET
23.80quote price arrow down-2.40 (-9.16%)
Volume
65
52 week range
4.08 - 43.40

...

Loading . . .

KEY STATS

  • Open25.60
  • Day High25.60
  • Day Low23.80
  • Prev Close23.80
  • 52 Week High43.40
  • 52 Week High Date01/20/21
  • 52 Week Low4.08
  • 52 Week Low Date03/17/20
  • Market Cap1,195.9M
  • Shares Out38.79M
  • 10 Day Average Volume1,173.9
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change217.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.91
  • P/E (TTM)-26.15
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Personalis Inc News

There is no recent news for this security.

Latest 04X-FF News From Our Partners

QUOTE FINDER

Profile

MORE
Personalis, Inc. is a cancer genomics company. The Company is focused on the development of therapies by providing molecular data about each patient’s cancer and immune response. The Company has designed NeXT Platform, which provides its biopharmaceutical customers with information on over 20,000 human genes, together with the immune system, in contrast to many cancer panels that cover over 50 to 500 genes. Its NeXT Platform is designed to provide analysis of both a tumor and...
Jonathan MacQuitty Ph.D.
Chairman
John West
President
Aaron Tachibana
Chief Financial Officer
Stephen Moore
General Counsel
Address
1330 Obrien Dr
Menlo Park, CA
94025-1436
United States